These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35801736)

  • 41. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amoxicillin/clavulanic acid-induced cholestatic liver injury after pediatric liver transplantation.
    Studniarz M; Czubkowski P; Cielecka-Kuszyk J; Jankowska I; Teisseyre M; Kamińska D; Markiewicz M; Broniszczak D; Pawłowska J
    Ann Transplant; 2012; 17(1):128-31. PubMed ID: 22466919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action.
    Ovadia C; Lövgren-Sandblom A; Edwards LA; Langedijk J; Geenes V; Chambers J; Cheng F; Clarke L; Begum S; Noori M; Pusey C; Padmagirison R; Agarwal S; Peerless J; Cheesman K; Heneghan M; Oude Elferink R; Patel VC; Marschall HU; Williamson C
    J Clin Apher; 2018 Dec; 33(6):638-644. PubMed ID: 30321466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report.
    Alvaro D; Onetti-Muda A; Moscatelli R; Atili AF
    Dig Liver Dis; 2001 Nov; 33(8):703-6. PubMed ID: 11785718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic Pruritus in an 18-Month-Old Male Infant Due to Anicteric Cholestasis.
    Nair VS; Chandrasekaran V; Jagadisan B; Biswal N
    J Trop Pediatr; 2017 Aug; 63(4):321-323. PubMed ID: 28082665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severe hepatitis with prolonged cholestasis and bile duct injury due the long-term use of ornidazole.
    Harputluoglu MM; Demirel U; Karadag N; Karahan D; Aladag M; Karincaoglu M; Hilmioglu F
    Acta Gastroenterol Belg; 2007; 70(3):293-5. PubMed ID: 18074740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials.
    Ramalingam SS; O'Byrne K; Boyer M; Mok T; Jänne PA; Zhang H; Liang J; Taylor I; Sbar EI; Paz-Ares L
    Ann Oncol; 2016 Mar; 27(3):423-9. PubMed ID: 26768165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dacomitinib in lung cancer: a "lost generation" EGFR tyrosine-kinase inhibitor from a bygone era?
    Ou SH; Soo RA
    Drug Des Devel Ther; 2015; 9():5641-53. PubMed ID: 26508839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrahepatic cholestasis induced by phenylbutazone.
    van de Merwe JP; van Blankenstein M; Wilson JH
    Digestion; 1981; 22(6):317-20. PubMed ID: 7333419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progressive Familial Intrahepatic Cholestasis Type 2 and Recurrence After Liver Transplantation: A Case Report.
    Romeres SGB; Trevizoli NC; Oliveira CAM; Obeid EJ; Arantes Ferreira GS; De Campos PB; Ullmann RFB; Rocha HC; Figueira AVF; Diaz LGG; Jorge FMF; Caja GON; Watanabe ALC; Sobroza de Mello E; Carvalho E
    Transplant Proc; 2022 Jun; 54(5):1370-1375. PubMed ID: 35718560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
    Mok TS; Cheng Y; Zhou X; Lee KH; Nakagawa K; Niho S; Chawla A; Rosell R; Corral J; Migliorino MR; Pluzanski A; Noonan K; Tang Y; Pastel M; Wilner KD; Wu YL
    Drugs; 2021 Feb; 81(2):257-266. PubMed ID: 33331989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Benign recurring intrahepatic cholestasis--a case report].
    Stremmel W; Scholten T; Miller B; Strohmeyer G
    Z Gastroenterol; 1984 Jun; 22(6):300-4. PubMed ID: 6464522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.
    Strubbe B; Geerts A; Van Vlierberghe H; Colle I
    Acta Gastroenterol Belg; 2012 Dec; 75(4):405-10. PubMed ID: 23402083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cholestasis in imipenem/cilastatin treatment].
    Schreiber C; May B
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():76-7. PubMed ID: 7483723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ticlopidine-induced cholestasis].
    Meyer MI; Kuhn M; Bühler H; Bertschinger P
    Schweiz Med Wochenschr; 1999 Oct; 129(39):1405-9. PubMed ID: 10542998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dacomitinib as a retreatment for advanced non-small cell lung cancer patient with an uncommon EGFR mutation.
    Morita A; Hosokawa S; Yamada K; Umeno T; Kano H; Kayatani H; Shiojiri M; Sakugawa M; Bessho A
    Thorac Cancer; 2021 Apr; 12(8):1248-1251. PubMed ID: 33651475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer patients: A network meta-analysis.
    Wu Z; Chen S; Du X; Wu Y; Xie X
    J Clin Pharm Ther; 2021 Apr; 46(2):310-318. PubMed ID: 33031574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.
    Ann Intern Med; 2002 Mar; 136(6):I65. PubMed ID: 11900516
    [No Abstract]   [Full Text] [Related]  

  • 59. Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of
    Zhu H; Wang S; Li L; Geng W; Wan X; Hua R; Wang D; Gao P
    Front Pediatr; 2022; 10():1012825. PubMed ID: 36330364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
    Nishio M; Kato T; Niho S; Yamamoto N; Takahashi T; Nogami N; Kaneda H; Fujita Y; Wilner K; Yoshida M; Isozaki M; Wada S; Tsuji F; Nakagawa K
    Cancer Sci; 2020 May; 111(5):1724-1738. PubMed ID: 32159882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.